Surgical management of advanced gastrointestinal stromal tumors after treatment with targeted systemic therapy using kinase inhibitors.
about
Clinical practice guidelines for patients with gastrointestinal stromal tumor in TaiwanIs conversion therapy possible in stage IV gastric cancer: the proposal of new biological categories of classificationCurrent management and prognostic features for gastrointestinal stromal tumor (GIST)Role of imatinib in the management of early, operable, and advanced GI stromal tumors (GISTs)Rare cystic liver lesions: a diagnostic and managing challenge.Strategies for modern biomarker and drug development in oncology.A single-arm phase II Austrian/German multicenter trial on continuous daily sunitinib in primary glioblastoma at first recurrence (SURGE 01-07).UK clinical practice guidelines for the management of gastrointestinal stromal tumours (GIST).Update on the treatment of gastrointestinal stromal tumors (GISTs): role of imatinib.Targeted therapy for cancer: the gastrointestinal stromal tumor model.Neoadjuvant imatinib in patients with locally advanced non metastatic GIST in the prospective BFR14 trial.NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors.Frequent KIT mutations in human gastrointestinal stromal tumors.In vivo fluorescence imaging of gastrointestinal stromal tumors using fluorophore-conjugated anti-KIT antibodyPerspective on updated treatment guidelines for patients with gastrointestinal stromal tumors.Clinical practice guideline for accurate diagnosis and effective treatment of gastrointestinal stromal tumor in KoreaUpdates on the management of gastrointestinal stromal tumors.Complete pathological response to Imatinib mesylate in an extraintestinal gastrointestinal stromal tumorClinical and therapeutic considerations of GISTThe role of adjuvant and neoadjuvant therapy in gastrointestinal stromal tumors.External beam radiation therapy for locally advanced and metastatic gastrointestinal stromal tumors.Treatment of gastrointestinal stromal tumor: focus on imatinib mesylate.Management of resectable gastrointestinal stromal tumor.A gist of gastrointestinal stromal tumors: A review.Metastasectomy for gastrointestinal stromal tumors.Tyrosine kinase inhibitors in the treatment of unresectable or metastatic gastrointestinal stromal tumors.The standard diagnosis, treatment, and follow-up of gastrointestinal stromal tumors based on guidelinesGastrointestinal stromal tumors-diagnosis and management: a brief review.Antiangiogenic tyrosine kinase inhibition related gastrointestinal perforations: a case report and literature review.Towards global consensus in the treatment of gastrointestinal stromal tumorPreoperative imatinib treatment in patients with advanced gastrointestinal stromal tumors: patient experiences and systematic review of 563 patients.Gastrointestinal tumors of the colon and rectumAdvances in the surgical management of gastrointestinal stromal tumorSurgical management of gastrointestinal stromal tumors: a single centre's experienceA case and literature review of complicated gastrointestinal stromal tumorsRecent advances and novel agents for gastrointestinal stromal tumor (GIST)Surgery after treatment with imatinib and/or sunitinib in patients with metastasized gastrointestinal stromal tumors: is it worthwhile?Current and emerging strategies for the management of imatinib-refractory advanced gastrointestinal stromal tumors.Feasibility and Timing of Cytoreduction Surgery in Advanced (Metastatic or Recurrent) Gastrointestinal Stromal Tumors During the Era of Imatinib.Long-Term Surgical Outcome of 1057 Gastric GISTs According to 7th UICC/AJCC TNM System: Multicenter Observational Study From Korea and Japan.
P2860
Q27027632-B2204618-E21B-4C1F-BC00-44734843AC58Q28084888-E1D124F8-FC37-4A09-A3F4-A1BFFF2CEE7BQ28391684-76EC4EE9-390E-4973-9D3A-C4D0F0096229Q28765146-165EBCDE-EC64-49BF-80DB-5C10DBA564D5Q30446819-72F05312-DE6B-4767-8B0E-694B1108E3C4Q30590270-8BC45CE4-6761-47CB-BA98-314B9C4BCEEBQ33411920-2E84E37A-EC22-4001-AA73-8CC542833CFAQ33612778-4EC95C0B-C0B5-4ADC-BE57-4D4045729EBDQ33644791-BC7F888A-2297-48BF-B046-94AC48A4B7A7Q33807742-407ABAED-68DE-4107-A43D-38549C442F50Q33821400-8D026454-39B0-4365-884D-667DEBA90F0DQ33921067-FC59FE5E-B445-4174-B947-D4EAFE41123EQ33985734-D84DC462-2DF9-46E6-956D-156E48895F8CQ34024845-1AA718EC-FB36-4D9E-B8DE-202F414B3967Q34202396-ECE08942-4704-4CCE-AAF0-0F78D11936AFQ34255550-F13AF134-23B0-4BD3-B2E7-56ABAD083F42Q34256921-9D67A12F-085C-45E6-A5C2-9D0CBD45A195Q34305765-662A6D0B-F1E2-4B1A-A596-66080966EB24Q34341168-46FF96D7-D39B-4EEE-9C8E-D41D3E4FDE15Q34359712-A0289439-C181-4D12-80E3-2E6E4AC85F89Q34461532-6F630B3D-6AAA-4E28-9527-9A0F8F473F6DQ34596126-53B688DA-D9BB-478B-A096-1274E800D8D0Q34604924-FC02B195-D68D-4046-AD79-9213116104A3Q34654203-AF6C2BB5-3B91-4BFA-87D1-F861D3834713Q34656880-516BC346-8A88-4B56-90B7-ACB894758E2DQ34662946-D86DCCFC-4B70-4ACD-AC2F-EEB1F071D62BQ34672344-412B2AAF-9987-4EE8-820E-C5CECDFC1953Q34986676-1FBFF605-3B3C-4A0C-AFF4-CA007873DF47Q35009777-BF478B01-EEA4-4C9E-8008-5C5ED3F90755Q35671104-33B2F2EF-0202-4A73-8BE9-C32367380FECQ35676187-41CCD596-BD24-4AD8-9C81-70E8EB121EBDQ35850185-DD492034-3C09-43A7-A9E1-B136682AE9FDQ36045267-52367EB1-02F8-4B29-8C1A-781768C22ACAQ36071979-1B6105DA-E582-42D7-B39A-29A7CB569560Q36088856-EB09BF8D-E4D4-456A-9933-5758887A65ACQ36118178-C53EC973-BAB9-4260-8DB3-970CC8A78BA8Q36173335-AB6DBC44-D365-4349-9EF2-81900E4FE76BQ36180074-59EEA632-15A2-4C72-8F9B-7D8877D8EBE1Q36194549-656C603B-61DC-41BD-B6B5-0CF6308F145BQ36195533-DA9E64DF-138B-4DB5-B24B-DB7108B01C03
P2860
Surgical management of advanced gastrointestinal stromal tumors after treatment with targeted systemic therapy using kinase inhibitors.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Surgical management of advance ...... erapy using kinase inhibitors.
@ast
Surgical management of advance ...... erapy using kinase inhibitors.
@en
Surgical management of advance ...... erapy using kinase inhibitors.
@nl
type
label
Surgical management of advance ...... erapy using kinase inhibitors.
@ast
Surgical management of advance ...... erapy using kinase inhibitors.
@en
Surgical management of advance ...... erapy using kinase inhibitors.
@nl
prefLabel
Surgical management of advance ...... erapy using kinase inhibitors.
@ast
Surgical management of advance ...... erapy using kinase inhibitors.
@en
Surgical management of advance ...... erapy using kinase inhibitors.
@nl
P2093
P356
P1476
Surgical management of advance ...... erapy using kinase inhibitors.
@en
P2093
Chandrajit P Raut
Christopher D M Fletcher
David Zahrieh
George D Demetri
Jayesh Desai
Jeffrey A Morgan
Matthew Posner
Monica M Bertagnolli
Suzanne George
P304
P356
10.1200/JCO.2005.05.3439
P407
P577
2006-05-01T00:00:00Z